Page last updated: 2024-10-28

guanfacine and Edema, Pulmonary

guanfacine has been researched along with Edema, Pulmonary in 2 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Research Excerpts

ExcerptRelevanceReference
"Guanfacine is a central alpha-2 agonist often prescribed for Attention-deficit hyperactive disorder as well as tic disorder, with a usual dose of 1-4 mg per day."5.62Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edema. ( Baker, Z; Bridwell, RE; Cibrario, A; Larson, NP; Oliver, JJ; Rosenthal, JB; Wray, J, 2021)
"Guanfacine is a central alpha-2 agonist often prescribed for Attention-deficit hyperactive disorder as well as tic disorder, with a usual dose of 1-4 mg per day."1.62Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edema. ( Baker, Z; Bridwell, RE; Cibrario, A; Larson, NP; Oliver, JJ; Rosenthal, JB; Wray, J, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ayata, R1
Fujita, M1
Harada, K2
Esaki, Y1
Koga, Y1
Hisamoto, Y1
Asami-Noyama, M1
Takeda, S1
Tsuruta, R1
Bridwell, RE1
Larson, NP1
Rosenthal, JB1
Wray, J1
Baker, Z1
Cibrario, A1
Oliver, JJ1

Other Studies

2 other studies available for guanfacine and Edema, Pulmonary

ArticleYear
A case of pulmonary edema due to guanfacine intoxication with measurement of serum guanfacine concentrations.
    The Journal of toxicological sciences, 2023, Volume: 48, Issue:12

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Del

2023
Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edema.
    The American journal of emergency medicine, 2021, Volume: 39

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Drug Overdose; Guanfacine; Heart Failure; Humans;

2021